Aerogen · 14 hours ago
Clinical Educator - Southern California
Aerogen is a global leader in acute care aerosol drug delivery, headquartered in Galway, Ireland. The Clinical Educator will support revenue growth in Southern California by delivering ongoing customer training and education, partnering with sales and marketing to meet customer needs, and providing clinical expertise to enhance patient care.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Drive Aerogen utilization and expansion in the region by providing ongoing customer training and education
Partner with sales and marketing to identify and assess customer needs; provide ongoing training through product validations, product implementations, therapy expansion, segment expansion, physician roundtables, and more
Deliver Continuing Education programs to customers throughout the assigned region
Champion product in-servicing to drive standardization of care throughout accounts; creates account ‘super users’ by providing ongoing clinical and professional expertise to end-users
Engages with Key Opinion Leaders (KOLs) to execute educational activities
Fulfill other duties as assigned
Qualification
Required
Bachelor's degree or equivalent
3+ years' experience as a Respiratory Therapist or Registered Nurse
0-2 years of medical device/pharmaceutical experience
Current RT or RN license or equivalent
Must be accomplished in a cross-functional team environment, exhibiting solid leadership skills
Ability to travel up to 80% of the time
Excellent communication, organization, and time management skills
Self-starter with the ability to multitask
Preferred
ICU or ED experience
Leadership experience
Benefits
Competitive commission plan.
Above market life insurance.
Opportunities for development and professional growth.
"Aerogen Connect" – our employee-led program that helps our global teams unite and have fun.
We donate 1% of profits and time to charities and organizations.
Company
Aerogen
Aerogen is a medical device and drug delivery company.
Funding
Current Stage
Late StageTotal Funding
$44.19MKey Investors
Disruptive Technologies Innovation FundEuropean Investment BankTemasek Holdings
2019-12-17Grant· $10.48M
2019-03-08Debt Financing· $33.7M
2018-11-05Private Equity
Recent News
Research and Markets
2025-11-03
Silicon Republic
2025-10-18
2025-09-13
Company data provided by crunchbase